Vault-13

PSYENCE BIOMEDICAL LTD

COM · CUSIP 74449F308

4 institutional holders -2 vs Q3 2025
41,95642.0k shares reported held*
$31.7kreported value*
1 new 2 added 0 reduced 3 sold out net sold ≈ $100.4k (-133.4k shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.76.

Trends to Q4 2025

Institutional holders

Managers reporting a position, each quarter

0246Q2 25: 6Q3 25: 6Q4 25: 44Q2 25Q3 25Q4 25
Numbers
QuarterHolders
Q2 20256
Q3 20256
Q4 20254

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
404Q3 25: 4 bought or addedQ3 25: 2 cut or sold outQ3 25Q4 25: 3 bought or addedQ4 25: 3 cut or sold outQ4 25
Numbers
QuarterBought or addedCut or sold out
Q3 202542
Q4 202533

Biggest buyers

Virtu Financial LLC Added +26,717+26.7k
UBS Group AG New +1,007+1.0k
BANK OF AMERICA CORP /DE/ Added +6+6

Biggest sellers

Parallel Advisors, LLC Sold out -151,250-151.2k
AdvisorShares Investments LLC Sold out -5,378-5.4k
OSAIC HOLDINGS, INC. Sold out -4,500-4.5k

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
Psyence Labs Ltd 13D · may seek influence new · filed 2026-06-03
Stated purposeThe Reporting Person acquired the Subject Shares pursuant to the exercise of an irrevocable put option granted to the Reporting Person under the Put Option Agreement. As previously disclosed by the Issuer in its Report on Form 6-K furnished to the Securities and Exchange Commission on February 13, 2026, the Reporting Person exercised the put option to require the Issuer to subscribe for US$5,000,000 of ordinary shares of the Reporting Person, with such subscription consideration to be satisfied through the issuance of Common Shares of the Issuer pursuant to the Share Exchange. The Reporting Person acquired the Subject Shares for investment purposes. The Reporting Person intends to review its investment in the Issuer on a continuing basis and may, from time to time and at any time, dependi… Full filing
 30.1% new 1.1m 2026-06-03

Fell to 5% or below in the last year: Weiner Jeffrey David (2.6%, 2026-06-10), Kaos Capital Ltd (4.9%, 2026-01-13)

Holders, Q4 2025

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Virtu Financial LLC 0.00% of their portfolio New York, NY 37,04237.0k $28.0k $28.0k 0.00% Added +26.7k +26,717
2 BANK OF AMERICA CORP /DE/ 0.00% of their portfolio CHARLOTTE, NC 3,3463.3k $2.5k $2.5k 0.00% Added +6 +6
3 UBS Group AG 0.00% of their portfolio ZURICH, V8 1,0071.0k $758 $758 0.00% New
4 Stonehage Fleming Financial Services Holdings Ltd 0.00% of their portfolio ST. HELIER, Y9 561561 $422 $422 0.00% Unchanged